Heska Corporation
HSKA
$119.84
Share price
0.00%
Change (1 day)
26.05%
Change (1 year)
Categories
Revenue for Heska Corporation (HSKA)
Revenue in 2023 (TTM): $0.25 B
According to Heska Corporation 's latest financial reports the company's current revenue (TTM) is $0.25 B. In 2022 the company made a revenue of $0.25 B an increase over the years 2021 revenue that were of $0.25 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Heska Corporation from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.25 B | -0.94% |
| 2022 | $0.25 B | 1.41% |
| 2021 | $0.25 B | 28.59% |
| 2020 | $0.19 B | 60.87% |
| 2019 | $0.12 B | -3.75% |
| 2018 | $0.12 B | -3.59% |
| 2017 | $0.13 B | 1.62% |
| 2016 | $0.13 B | 24.37% |
| 2015 | $0.10 B | 16.43% |
| 2014 | $89.83 M | 14.68% |
| 2013 | $78.33 M | 7.6% |
| 2012 | $72.8 M | 3.91% |
| 2011 | $70.06 M | 7.05% |
| 2010 | $65.45 M | -13.51% |
| 2009 | $75.67 M | -7.32% |
| 2008 | $81.65 M | -0.83% |
| 2007 | $82.33 M | 9.69% |
| 2006 | $75.06 M | 8.1% |
| 2005 | $69.43 M | 2.58% |
| 2004 | $67.69 M | 3.62% |
| 2003 | $65.32 M | 27.27% |
| 2002 | $51.32 M | 6.3% |
| 2001 | $48.28 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $52.22 B | 20,388.21% | 🇨🇭 Switzerland |
 Pfizer PFE | $92.95 B | 36,367.78% | 🇺🇸 USA |
 Eli Lilly LLY | $27.69 B | 10,764.14% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | $3.43 B | 1,246.07% | 🇺🇸 USA |
 Zoetis ZTS | $8.09 B | 3,075.51% | 🇺🇸 USA |
 Merck MRK | $57.86 B | 22,603.70% | 🇺🇸 USA |
 Petco WOOF | $6.11 B | 2,299.44% | 🇺🇸 USA |